Welcome
Pharmaceutical & Life Sciences News

Whistle-Blower Suit Claiming Duke Faked Data Is Warning Signal

Sept. 8, 2016, 4:00 AM

The increased use of the whistle-blower statute in research misconduct cases could significantly shift how universities and principal investigators manage research grants, attorneys told Bloomberg BNA.

The issue was spotlighted when Joseph M. Thomas, a former employee of Duke University’s pulmonary division, filed a complaint against the university under the False Claims Act (FCA). Thomas alleged that former colleague Erin N. Potts-Kant, her supervisor and the university had falsified data in research funded by the National Institutes of Health and the Environmental Protection Agency (United States ex rel. Joseph M. Thomas v. Duke Univ.unsealed).

The falsifications were made...

To read the full article log in. To learn more about a subscription click here.